J. Alexander Hood , II
Pomerantz LLP
- Address of record
- 600 Third Avenue, 20th Floor, New York, NY 10016, 212-661-1100
- ahood@pomlaw.com
- Phone
- (212) 661-1100
- Fax
- Fax (212) 661-8665
Contact details as filed with the court in the cases below.
Case history
Publicly tracked matters where this attorney is listed as counsel.
Sea Limited 2023 Securities Litigation Settlement
Sea Limited and its executives issued materially false and misleading statements regarding the company's Garena digital entertainment and Shoppe e-commerce business segments. The defendants deny all claims and allegations, but agreed to settle for $46 million.
- Settlement fund
- $46M
- Claim deadline
- June 23, 2025
- Represents
- Yahya Muraweh, Ubaydullo Mirvaydulloev, George Vayner, Anil Bhandari
Tattooed Chef Securities Settlement
Tattooed Chef, Inc. faced a securities lawsuit alleging that purchasers of the company's common stock were damaged. The defendant has agreed to settle all claims in the action for $4,750,000 in cash without admitting wrongdoing.
- Settlement fund
- $4.8M
- Claim deadline
- August 4, 2026
- Represents
- Ben Ganje, Mohamed Saad, Nassib Awad
Wells Fargo Securities Action Settlement
Wells Fargo allegedly made false and misleading statements about its diversity hiring initiative, the Diverse Search Requirement. The company failed to disclose that it was conducting widespread "fake" or sham interviews of diverse candidates under this policy. When The New York Times revealed this conduct on June 9, 2022, Wells Fargo shareholders suffered losses. Wells Fargo denies all allegations and admits no wrongdoing.
- Settlement fund
- $85M
- Claim deadline
- April 14, 2026
- Represents
- Khosrow Ardalan, Employees Retirement System of Rhode Island
Virgin Galactic Holdings Securities Settlement
Plaintiffs claim that defendants violated federal securities laws in connection with publicly traded shares of Virgin Galactic Holdings, Inc. and Social Capital Hedosophia Holdings Corp. Defendants deny all wrongdoing and deny that they violated any laws or that any member of the settlement class suffered damages.
- Settlement fund
- $8.5M
- Claim deadline
- August 13, 2026
- Represents
- Shane Lavin
FibroGen, Inc. Securities Litigation Settlement
FibroGen and its executives allegedly misrepresented the safety profile and Phase III trial results of its anti-anemia drug Roxadustat in filings with the FDA. Investors claim the company's stock price was artificially inflated by these false statements and declined when the truth was revealed. The defendants deny all allegations of wrongdoing.
- Settlement fund
- $28.5M
- Claim deadline
- Represents
- Cesare Grazioli
Tricida Securities Settlement
Tricida, Inc. and defendant Gerrit Klaerner are alleged to have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The defendant denies all claims and wrongdoing. The settlement resolves these allegations without admission of liability.
- Settlement fund
- $14.3M
- Claim deadline
- October 1, 2025
- Represents
- Michael Pardi
Boston Scientific Securities Litigation Settlement
Boston Scientific Corporation and its executives allegedly made false and misleading statements regarding the company's Lotus Edge medical device in violation of federal securities laws. Investors who purchased Boston Scientific common stock during the relevant period were allegedly harmed by these misstatements.
- Settlement fund
- $38.5M
- Claim deadline
- Represents
- Enrique Jevons
“Recovery” and “exposure” refer to total disclosed settlement funds in associated cases, not money personally won or lost by an attorney. Settlements generally resolve disputed allegations without a finding that either side won. Data comes from public court dockets and may be incomplete.